Is TCF7L2 useful for fatigue?

TCF7L2 is one of the most robustly replicated genetic risk loci for type 2 diabetes, identified through large GWAS. Variants like rs7903146 increase diabetes risk by affecting pancreatic beta-cell function. However, there is no direct evidence linking TCF7L2 to fatigue. Fatigue is a multifactorial symptom; while undiagnosed diabetes can cause tiredness, the gene variant alone does not predict current energy levels or fatigue. Some direct-to-consumer genetic tests market TCF7L2 as a 'fatigue gene' or 'energy gene', but this is not supported by clinical evidence. The American Diabetes Association and other guidelines do not recommend TCF7L2 testing for fatigue or general health. For persistent fatigue, standard medical workup (CBC, thyroid, iron, vitamin D, sleep assessment) is far more informative. Therefore, TCF7L2 is not useful for fatigue assessment. Evidence level: marketing – claims lack scientific backing for this specific use.